Di-Syntramine
Brand names,
Di-Syntramine
Analogs
Di-Syntramine
Brand Names Mixture
Di-Syntramine
Chemical_Formula
C19H35NO2
Di-Syntramine
RX_link
http://www.rxlist.com/cgi/generic/dicyc.htm
Di-Syntramine
fda sheet
Di-Syntramine
msds (material safety sheet)
Di-Syntramine
Synthesis Reference
No information avaliable
Di-Syntramine
Molecular Weight
309.487 g/mol
Di-Syntramine
Melting Point
No information avaliable
Di-Syntramine
H2O Solubility
No information avaliable
Di-Syntramine
State
Solid
Di-Syntramine
LogP
5.476
Di-Syntramine
Dosage Forms
Capsule
Di-Syntramine
Indication
For the treatment of functional bowel/irritable bowel syndrome
Di-Syntramine
Pharmacology
Dicyclomine is an anticholinergic drug, a medication that reduces the effect of acetylcholine, a chemical released from nerves that stimulates muscles, by blocking the receptors for acetylcholine on smooth muscle (a type of muscle). It also has a direct relaxing effect on smooth muscle. Dicyclomine is used to treat or prevent spasm in the muscles of the gastrointestinal tract in the irritable bowel syndrome. In addition, Dicyclomine inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions.
Di-Syntramine
Absorption
No information avaliable
Di-Syntramine
side effects and Toxicity
No information avaliable
Di-Syntramine
Patient Information
Dicyclomine may produce drowsiness or blurred vision. The patient should be warned not to engage in activities
requiring mental alertness, such as operating a motor vehicle or other machinery or to perform hazardous work while
taking this drug.
Dicyclomine is contraindicated in infants less than 6 months of age and in nursing mothers. .
In the presence of a high environmental temperature, heat prostration can occur with drug use (fever and heat
stroke due to decreased sweating).
If symptoms occur the drug should be discontinued and a physician contacted.
Di-Syntramine
Organisms Affected
Humans and other mammals